Efficacy of oral palonosetron compared to intravenous palonosetron for the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy: a phase 3 trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1433-7339
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Efficacy of oral palonosetron compared to intravenous palonosetron for the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy: a phase 3 trial ; volume:21 ; number:5 ; day:26 ; month:1 ; year:2013 ; pages:1453-1460 ; date:5.2013
Supportive care in cancer ; 21, Heft 5 (26.1.2013), 1453-1460, 5.2013
- Urheber
-
Boccia, Ralph
Grunberg, Steven
Franco-Gonzales, Edwin
Rubenstein, Edward
Voisin, Daniel
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00520-012-1691-5
- URN
-
urn:nbn:de:101:1-2019113010200079730514
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Boccia, Ralph
- Grunberg, Steven
- Franco-Gonzales, Edwin
- Rubenstein, Edward
- Voisin, Daniel
- SpringerLink (Online service)
Ähnliche Objekte (12)
Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study
Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting
Serum iron levels increased by cancer chemotherapy correlate the chemotherapy-induced nausea and vomiting
Efficacy of triple antiemetic therapy (palonosetron, dexamethasone, aprepitant) for chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based, moderately emetogenic chemotherapy
Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting
Correction to: Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting
SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2016)
A Study on Utilization and Evaluation of Antiemetics in Chemotherapy‑induced Nausea and Vomiting
Chemotherapy-induced nausea and vomiting in patients with breast cancer: a prospective cohort study
Olanzapine treatment effectively relieves breakthrough chemotherapy-induced nausea and vomiting: a real-world experience
Searching for perfection: further progress in management of chemotherapy-induced nausea and vomiting—introduction
Acupuncture Point Selection Patterns for Chemotherapy-Induced Nausea and Vomiting: A Data Mining Analysis
Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study
Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting
Serum iron levels increased by cancer chemotherapy correlate the chemotherapy-induced nausea and vomiting
Efficacy of triple antiemetic therapy (palonosetron, dexamethasone, aprepitant) for chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based, moderately emetogenic chemotherapy
Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting
Correction to: Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting
SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2016)
A Study on Utilization and Evaluation of Antiemetics in Chemotherapy‑induced Nausea and Vomiting
Chemotherapy-induced nausea and vomiting in patients with breast cancer: a prospective cohort study
Olanzapine treatment effectively relieves breakthrough chemotherapy-induced nausea and vomiting: a real-world experience
Searching for perfection: further progress in management of chemotherapy-induced nausea and vomiting—introduction
Acupuncture Point Selection Patterns for Chemotherapy-Induced Nausea and Vomiting: A Data Mining Analysis
Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study
Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting
Serum iron levels increased by cancer chemotherapy correlate the chemotherapy-induced nausea and vomiting
Efficacy of triple antiemetic therapy (palonosetron, dexamethasone, aprepitant) for chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based, moderately emetogenic chemotherapy
Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting
Correction to: Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting
SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2016)
A Study on Utilization and Evaluation of Antiemetics in Chemotherapy‑induced Nausea and Vomiting
Chemotherapy-induced nausea and vomiting in patients with breast cancer: a prospective cohort study
Olanzapine treatment effectively relieves breakthrough chemotherapy-induced nausea and vomiting: a real-world experience
Searching for perfection: further progress in management of chemotherapy-induced nausea and vomiting—introduction